Skip to content
healthcare.dev

Claritin Reditabs

NDC 11523-7202, Loratadine, tablet, orally disintegrating, from Bayer HealthCare LLC.

Product NDC
11523-7202
Status
Listed
Labeler
Bayer HealthCare LLC
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA021993
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11523-7202 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LORATADINE5 mg/1
Package NDCNDC-11Package
11523-7202-1115237202013 BLISTER PACK in 1 CARTON (11523-7202-1) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
11523-7202-3115237202031 BLISTER PACK in 1 CARTON (11523-7202-3) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 11523-7202 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11523-7202 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11523-7202. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.